The Role of Nuclear Factor Kappa B in the Pathogenesis of Pulmonary Diseases: Implications for Therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705–16
Schwartz MD, Moore EE, Moore FA, et al. Nuclear factor-kappaB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24: 1285–92
Blackwell TS, Holden EP, Blackwell TR, et al. Activation of NF-kappaB in rat lung by treatment with endotoxin: modulation with N-acetyalcysteine. J Immunol 1996; 157: 1630–7
Ghosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225–60
Henkel T, Machleidt T, Alkalay I, et al. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappaB. Nature 1993; 365: 182–5
Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to Interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 1999; 19: 4798–805
Zhong H, SuYang H, Erdjument-Bromage H, et al. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89: 413–24
Arenzana-Seisdedos F, Thompson J, Rodriguez MS, et al. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 1995; 15: 2689–96
Chen L-F, Fischle W, Verdin E, et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293: 1653–7
Mercurio F, Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 1999; 11: 226–32
Opal SM, Huber CE. Bench-to-bedside review: toll-like receptors and their role in septic shock. Crit Care 2002; 6(2): 125–36
Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336(15): 1066–71
Moine P, McIntyre R, Schwartz MD, et al. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 2000; 13(2): 85–91
Shenkar R, Yum HK, Arcaroli J, et al. Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia. Am J Physiol Lung Cell Mol Physiol 2001; 281(2): L418–26
Pepperl S, Dorger M, Ringel F, et al. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2001; 280(5): L905–13
Pugin J, Dunn I, Jolliet P, et al. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998; 275 (6 Pt 1): L1040–50
Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-kappaB expression. Am J Physiol 1999; 276 (6 Pt 1): L909–16
Janssen-Heininger YM, Macara I, Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 1999; 20(5): 942–52
Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344(10): 699–709
Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29 (7 Suppl.): S48–51
Joyce DE, Grinnell BW. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 2002; 30 (5 Suppl.): S288–93
Zhao S, Qi Y, Liu X, et al. Activation of NF-kappa B in bronchial epithelial cells from children with asthma. Chin Med J (Engl) 2001; 114(9): 909–11
Wilson SJ, Wallin A, Della-Cioppa G, et al. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001; 164(6): 1047–52
Shukla A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol 2000; 23(2): 182–7
Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510–3
Kim I, Moon S, Kim S, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001; 276(10): 7614–20
Dikov M, Oyama T, Cheng P, et al. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Cancer Res 2001; 61(5): 2015–21
Kasahara Y, Tuder R, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106(11): 1311–9
Baldwin Jr AS. The NF-kappaB and IkappaB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–81
Nishikawa M, Kakemizu N, Ito T, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999; 20: 189–98
Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor kappaB in pulmonary diseases. Chest 2000; 117: 1482–7
Teramoto S, Kume H. The role of nuclear factor-kappaB activation in airway inflammation following adenovirus infection and COPD. Chest 2000; 119(4): 1294–5
Cafferata EGA, Guerrico AMG, Pivetta OH, et al. NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta. J Biol Chem 2001; 276(18): 15441–4
Brouillard F, Bouthier M, Leclerc T, et al. NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta. J Biol Chem 2001; 276(12): 9486–91
Venkatakrishnan A, Stecenko AA, King G, et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000; 23(3): 396–403
Weber AJ, Soong G, Bryan R, et al. Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl-channel function. Am J Physiol Lung Cell Mol Physiol 2001; 281(1): L71–8
Scheid P, Kempster L, Griesenbach U, et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001; 17(1): 27–35
DiMango E, Ratner AJ, Bryan R, et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998; 101(11): 2598–605
Ghio AJ, Marshall BC, Diaz JL, et al. Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum. Am J Respir Crit Care Med 1996; 154 (3 Pt 1): 783–8
Drent M, van den Berg R, Haenen GR, et al. NF-kappaB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18(1): 50–6
Kreipe H, Radzun HJ, Heidorn K, et al. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. Lab Invest 1990; 62(6): 697–703
Conron M, Bondeson J, Pantelidis P, et al. Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways. Am J Respir Cell Mol Biol 2001; 25(2): 141–9
Baldwin Jr AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107(3): 241–6
Rosell R, Taron M, O’Brate A. Predictive molecular markers in non-small cell lung cancer. Curr Opin Oncol 2001; 13(2): 101–9
Jones DR, Broad RM, Madrid LV, et al. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Cardiovasc Surg 2000; 70(3): 930–6
Cusack JJ, Liu R, Baldwin Jr AS. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and xenograft models is overcome by inhibition of nuclear factorkappa activation. Cancer Res 2000; 60: 2323–30
Haley KJ, Patidar K, Zhang F, et al. Tumor necrosis factor induces neuroendocrine differentiation in small cell lung cancer cell lines. Am J Physiol 1998; 275 (2 Pt 1): L311–21
Batra RK, Guttridge DC, Brenner DA, et al. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am J Respir Cell Mol Biol 1999; 21(2): 238–45
Milligan SA, Nopajaroonsri C. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. Anticancer Res 2001; 21(1A): 39–44
Ding M, Shi X, Castranova V, et al. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J Environ Pathol Toxicol Oncol 2000; 19(1-2): 129–38
Sacks M, Gordon J, Bylander J. Silica-induced pulmonary inflammation in rats: activation of NF-kappaB and its suppression by dexamethasone. Biochem Biophys Res Commun 1998; 253: 181–4
Kennedy T, Ghio AJ, Reed W, et al. Copper dependent inflammation and nuclear factor kappa B activation by particulate air pollution. Am J Respir Cell Mol Biol 1998; 19: 366–78
Takizawa H, Ohtoshi T, Kawasaki S, et al. Diesel exhaust particles induce NF-kB activity in human bronchial epithelial cells in vitro: importance in cytokine transcription. J Immunol 1999; 162: 4705–11
Quay JL, Reed W, Samet J, et al. Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation. Am J Respir Cell Mol Biol 1998; 19: 98–106
Kawasaki S, Takizawa H, Takami K, et al. Benzene-extracted components are important for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001; 24(4): 419–26
Bonvallot V, Baeza-Squiban A, Baulig A, et al. Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol 2001; 25(4): 515–21
Dai J, Churg A. Relationship of fiber surface iron and active oxygen species to expression of procollagen, PDGF-A, and TGF-beta(1) in tracheal explants exposed to amosite asbestos. Am J Respir Cell Mol Biol 2001; 24(4): 427–35
Gilmour PS, Beswick PH, Brown DM, et al. Detection of surface free radical activity of respirable industrial fibres using supercoiled phi X174 RF1 plasmid DNA. Carcinogenesis 1995; 16: 2973–9
Janssen YM, Driscoll KE, Howard B, et al. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 1997; 151(2): 389–401
Janssen YM, Barchowsky A, Treadwell M, et al. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A 1995; 92(18): 8458–62
Cheng N, Shi X, Ye J, et al. Role of transcription factor NF-kappaB in asbestos-induced TNFalpha response from macrophages. Exp Mol Pathol 1999; 66(3): 201–10
Brown DM, Beswick PH, Donaldson K. Induction of nuclear translocation of NF-kappaB in epithelial cells by respirable mineral fibres. J Pathol 1999; 189(2): 258–64
Robledo R, Mossman BT. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol 1999; 180(2): 158–66
Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmcol 2002; 54(4): 453–72
Sheehan M, Wong HR, Hake PW, et al. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 2002; 61(5): 953–63
Adams J, Palombella VJ, Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999; 59: 2615–22
Javelaud D, Poupon MF, Wietzerbin J, et al. Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 2002; 98(2): 193–8
Romanelli A, Pedone C, Saviano M, et al. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites. Eur J Biochem 2001; 268(23): 6066–75
Ueno T, Sawa Y, Kitagawa-Sakakida S, et al. Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. J Thorac Cardiovasc Surg 2001; 122(4): 720–7
Sakaue G, Shimaoka M, Fukuoka T, et al. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 2001; 12(10): 2079–84
Tonita T, Takeuchi E, Tonita N, et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligo-nucleotides as a gene therapy. Arthritis Rheum 1999; 42(12): 2532–42